Ank1: A Protein with Potential as A Drug Target Or Biomarker (G286)

Target Name: ANK1

NCBI ID: G286

ANK1

Ank1: A Protein with Potential as A Drug Target Or Biomarker

ANK1 (ANK1 variant 9) is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and intestines. It is a member of the ANK1 gene family, which is known for its role in cell signaling and inflammation.

One of the unique features of ANK1 is its ability to interact with multiple signaling pathways, including TGF-β, NF-kappa-B, and MAPK/ERK. This makes ANK1 a promising target for drug development.

ANK1 has also been shown to play a role in several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, ANK1 has been shown to be overexpressed in various types of cancer, including breast, ovarian, and prostate cancer. This suggests that ANK1 may be a useful biomarker for these diseases.

In addition to its potential as a drug target, ANK1 has also been shown to have potential as a biomarker. The ANK1 gene has been shown to be downregulated in a variety of diseases, including neurodegenerative diseases, cancer, and autoimmune disorders. This suggests that ANK1 may be a useful biomarker for these conditions.

Furthermore, ANK1 has been shown to be involved in several signaling pathways that are important for human health. For example, ANK1 has been shown to be involved in the regulation of inflammation, cell signaling, and neurotransmission. This suggests that ANK1 may be a useful target for drugs that are designed to modulate these pathways.

In conclusion, ANK1 is a protein that has the potential to be a drug target or biomarker. Its unique ability to interact with multiple signaling pathways and its involvement in several diseases make it an attractive target for further research. Further studies are needed to determine the full role of ANK1 in cell signaling and disease.

Protein Name: Ankyrin 1

Functions: Attaches integral membrane proteins to cytoskeletal elements; binds to the erythrocyte membrane protein band 4.2, to Na-K ATPase, to the lymphocyte membrane protein GP85, and to the cytoskeletal proteins fodrin, tubulin, vimentin and desmin. Erythrocyte ankyrins also link spectrin (beta chain) to the cytoplasmic domain of the erythrocytes anion exchange protein; they retain most or all of these binding functions

The "ANK1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANK1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets